News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,096 Results
Type
Article (41368)
Company Profile (263)
Press Release (689449)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (204850)
Career Advice (2032)
Deals (35583)
Drug Delivery (130)
Drug Development (81526)
Employer Resources (173)
FDA (16512)
Job Trends (14983)
News (346842)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2596)
Accelerated approval (48)
Adcomms (26)
Allergies (171)
Alliances (49580)
ALS (211)
Alzheimer's disease (1801)
Antibody-drug conjugate (ADC) (449)
Approvals (16898)
Artificial intelligence (668)
Autoimmune disease (294)
Automation (56)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (170)
Bladder cancer (196)
Brain cancer (72)
Breast cancer (754)
Cancer (5839)
Cardiovascular disease (472)
Career advice (1724)
Career pathing (42)
CAR-T (331)
CDC (56)
Celiac Disease (3)
Cell therapy (899)
Cervical cancer (47)
Clinical research (70869)
Collaboration (2068)
Company closure (5)
Compensation (1404)
Complete response letters (80)
COVID-19 (2743)
CRISPR (108)
C-suite (1134)
Cystic fibrosis (152)
Data (7943)
Decentralized trials (3)
Denatured (27)
Depression (161)
Dermatology (87)
Diabetes (587)
Diagnostics (6936)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (322)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (284)
Earnings (92120)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119576)
Executive appointments (1082)
FDA (20250)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1732)
Gene editing (234)
Generative AI (56)
Gene therapy (724)
GLP-1 (1055)
Government (4732)
Grass and pollen (6)
Guidances (408)
Healthcare (19009)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (289)
Immuno-oncology (93)
Indications (195)
Infectious disease (3083)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (292)
Interviews (319)
IPO (16667)
IRA (50)
Job creations (3647)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (101)
Layoffs (563)
Leadership (39)
Legal (7953)
Liver cancer (100)
Longevity (32)
Lung cancer (766)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1054)
MASH (190)
Medical device (13939)
Medtech (14064)
Mergers & acquisitions (20171)
Metabolic disorders (1504)
mRNA (206)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (417)
Neuropsychiatric disorders (105)
Neuroscience (3312)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4530)
Now hiring (78)
Obesity (703)
Opinion (288)
Ovarian cancer (222)
Pain (257)
Pancreatic cancer (306)
Parkinson's disease (362)
Partnered (33)
Patents (599)
Patient recruitment (673)
Peanut (62)
People (59610)
Pharmaceutical (58)
Pharmacy benefit managers (32)
Phase 1 (22087)
Phase 2 (31224)
Phase 3 (23228)
Pipeline (8828)
Policy (318)
Postmarket research (2569)
Preclinical (9420)
Press Release (64)
Prostate cancer (304)
Psychedelics (54)
Radiopharmaceuticals (324)
Rare diseases (1079)
Real estate (5973)
Recruiting (70)
Regulatory (25419)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (176)
Series A (289)
Series B (213)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3641)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (62)
Vaccines (1093)
Venture capital (108)
Weight loss (451)
Women's health (128)
Worklife (20)
Date
Today (134)
Last 7 days (775)
Last 30 days (3556)
Last 365 days (30186)
2026 (12848)
2025 (30171)
2024 (35208)
2023 (40072)
2022 (51173)
2021 (55707)
2020 (54081)
2019 (46537)
2018 (35015)
2017 (32107)
2016 (31481)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (349)
Arkansas (14)
Asia (39686)
Australia (6512)
California (13329)
Canada (3781)
China (1344)
Colorado (567)
Connecticut (579)
Delaware (411)
Europe (85896)
Florida (2000)
Georgia (428)
Hawaii (3)
Idaho (62)
Illinois (1054)
India (90)
Indiana (601)
Iowa (23)
Japan (540)
Kansas (131)
Kentucky (50)
Louisiana (41)
Maine (76)
Maryland (1597)
Massachusetts (9502)
Michigan (366)
Minnesota (721)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3503)
New Mexico (29)
New York (3489)
North Carolina (1692)
North Dakota (9)
Northern California (6685)
Ohio (399)
Oklahoma (23)
Oregon (41)
Pennsylvania (2683)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5263)
Tennessee (213)
Texas (2126)
United States (47014)
Utah (398)
Vermont (1)
Virginia (323)
Washington D.C. (80)
Washington State (1062)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
731,096 Results for "predicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Predicine Submits First Module of PMA Application to FDA for PredicineCARE™ as a Companion Diagnostic Assay in Bladder Cancer
September 3, 2025
·
2 min read
Biotech Bay
UPDATE: Predicine Introduces PredicineCARE™ NGS Kit for Tumor Profiling
Predicine, Inc., a leading molecular insights company, announced the release of its innovative PredicineCARE™ NGS Kit.
April 11, 2024
·
2 min read
Biotech Bay
Predicine Introduces PredicineCARE™ NGS Kit for Global Clinical Trials, CDx Development and Patient Testing
Predicine, Inc., a leading molecular insights company, announced the release of its innovative PredicineCARE™ NGS Kit.
April 5, 2024
·
2 min read
Business
Predicine Announces Collaboration with Apollomics to Develop PredicineCARE™ as a Companion Diagnostic Assay in Lung Cancer
Predicine, Inc., a leading molecular insights company, announced a collaboration with Apollomics, Inc.
April 5, 2024
·
2 min read
Biotech Bay
Predicine to Present 15 Liquid Biopsy Studies at AACR 2024
Predicine, Inc. A leading precision oncology company, announced that it will present data from 15 ctDNA studies at AACR 2024, spotlighting the clinical utility of Predicine’s genomic and epigenomic liquid biopsy solutions for patient selection, disease monitoring, and disease mechanism studies.
April 5, 2024
·
3 min read
Business
Predicine Announces Collaboration with Janssen to Develop PredicineCARE™ as a Companion Diagnostic Assay in Localized Bladder Cancer
Predicine, Inc., a leading molecular insights company, announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company.
January 8, 2024
·
2 min read
Biotech Bay
Predicine announces six studies showcasing MRD and liquid biopsy innovations at ESMO 2023
Predicine, a pioneer in the liquid biopsy, announce its participation in the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
October 17, 2023
·
2 min read
Biotech Bay
Predicine to Introduce PredicineALERT™ MRD Assay and Present Twelve Posters at AACR 2023 Conference
Predicine, a global molecular insights company, announced that it will present data from 12 studies and introduce PredicineALERT™, a next-generation Minimal Residual Disease liquid biopsy assay at the 2023 AACR Conference on April 14-19, 2023.
April 14, 2023
·
3 min read
Biotech Bay
Predicine to Present Four Studies at 2023 ASCO Genitourinary (GU) Symposium Highlighting the Technical and Clinical Utility of Predicine’s Liquid Biopsy Based Assays
Predicine, a global molecular insights company, is committed to advancing genitourinary cancer detection and treatment decisions through its proprietary non-invasive next-generation sequencing assays.
February 16, 2023
·
2 min read
Biotech Bay
Predicine to Introduce PredicineALERT™ MRD Assay and Present Two ctDNA Studies in Genitourinary Cancers at AUA 2023 Annual Meeting
Predicine announced that it will present two studies and introduce PredicineALERT™ Minimal Residual Disease liquid biopsy assay to genitourinary cancers at the 2023 American Urological Association Annual Meeting held in Chicago between April 28 to May 1, 2023.
April 28, 2023
·
2 min read
1 of 73,110
Next
